Authors and Disclosures
Arti Hurria, MDa, Kevin P. High, MD, MSb, Lona Mody, MDc, Frances McFarland Horne, PhD, MAd, Marcus Escobedo, MPAe, Jeffrey Halter, MDf, William Hazzard, MDb, Kenneth Schmader, MDg,h, Heidi Klepin, MD, MSi, Sei Lee, MD, MASj, Una E. Makris, MD, MSCSk, Michael W. Rich, MDl, Stephanie Rogers, MDm, Jocelyn Wiggins, BM, BChf, Rachael Watman, MSWe, Jennifer Choi, BSa, Nancy Lundebjerg, MPAn and Susan Zieman, MD, PhDo
aCancer and Aging Research Program, City of Hope National Medical Center, Duarte, California; bSchool of Medicine, Wake Forest University, Winston-Salem, North Carolina; cUniversity of Michigan, Ann Arbor, Michigan; dAssociation of Specialty Professors, Alexandria, Virginia; eJohn A. Hartford Foundation, New York, New York; fUniversity of Michigan Health System, Ann Arbor, Michigan; gDuke University, Durham, North Carolina; hGeriatric Research Education and Clinical Center, Durham Veterans Affairs, Durham, North Carolina; iWake Forest University, Winston-Salem, North Carolina; jUniversity of California, San Francisco, San Francisco, California; kUniversity of Texas Southwestern Medical Center, Dallas, Texas; lWashington University in St. Louis, St. Louis, Missouri; mWichita State University, Wichita, Kansas; nAmerican Geriatrics Society, New York, New York; and oNational Institute on Aging, National Institutes of Health, Bethesda, Maryland.
Address correspondence to
Arti Hurria, Cancer and Aging Research Program, City of Hope, 1500 E Duarte Rd, Duarte, CA 91001. E-mail: email@example.com
Conflict of Interest
Dr. Hurria is supported by the NIA (R01AG037037, U13AG038151, U13 AG048721), the National Cancer Institute (R01 CA172119, R25CA183723), and the Breast Cancer Research Foundation. Dr. Hurria is principal investigator of investigator-initiated research supported by Celgene and GalaxoSmithKline. She serves as a consultant for Gtx, Inc., Boehringer Ingelheim Pharmaceuticals, On Q Health, and…